Clinical Trial Update: Hydroxyzine and Risk of Prolongation of QT Interval

View source ↗

Summary

This clinical trial update notes a potential risk that hydroxyzine may prolong the QT interval, which can be associated with arrhythmias; the study status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome

Drugs mentioned

• Hydroxyzine (hydroxyzine)

Snippet

Sponsor: University Hospital, Caen | Conditions: Hydroxyzine, Long QT Syndrome | Status: UNKNOWN